Respiratory health outcomes are not evenly distributed across populations, with marginalized and underserved groups facing disproportionate burdens of lung disease. Factors such as socioeconomic status, environmental exposures, limited healthcare access, and systemic inequities all contribute to these disparities. Communities exposed to indoor biomass fuel, urban air pollution, or occupational hazards are at greater risk of developing chronic respiratory conditions. Moreover, delayed diagnosis, poor access to essential medications, and cultural barriers compound the challenges faced by vulnerable populations, leading to higher morbidity and mortality.
Addressing lung health disparities requires coordinated action at multiple levels, combining public health policy with community engagement. Targeted interventions may include mobile clinics, telehealth services, and expanded vaccination programs to bring preventive care into underserved regions. Clean air initiatives, workplace safety regulations, and equitable access to medications reduce structural risk factors. Education campaigns designed in collaboration with community leaders foster trust and improve health-seeking behaviors. Research focused on understanding social determinants of respiratory health is equally important for guiding interventions. By prioritizing equity and accessibility, health systems can reduce the disproportionate burden of respiratory disease and ensure that every population has the opportunity to achieve optimal lung health.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation